ALTO NEUROSCIENCE INC (ANRO) Stock Earnings Estimates
USA - New York Stock Exchange - NYSE:ANRO - US02157Q1094 - Common Stock
16.61 USD
-0.57 (-3.32%)
16.48 USD
-0.13 (-0.78%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 210K | N/A -100.00% | 2.71M | 41.671M 1,437.68% | 261.12M 526.62% | 777.81M 197.87% | 1.323B 70.09% | 2.317B 75.13% | ||||||
| EBITDA YoY % growth | -11.911M | N/A -142.21% | N/A -29.76% | N/A -81.93% | -72.318M -6.18% | -106.896M -47.81% | -156.57M -46.47% | -201.654M -28.79% | -148.614M 26.30% | -39.372M 73.51% | N/A | N/A | N/A | |
| EBIT YoY % growth | -12.056M | N/A -142.14% | -42.2M -29.52% | -74.975M -81.46% | -68.831M -0.32% | -88.264M -28.23% | -122.044M -38.27% | -137.297M -12.50% | -136.891M 0.30% | 33.773M 124.67% | 453.13M 1,241.69% | 780.56M 72.26% | 1.203B 54.12% | |
| Operating Margin | -5,740.95% | N/A | N/A | N/A | N/A | N/A | N/A | -5,066.29% | -328.50% | 12.93% | 58.26% | 59.00% | 51.92% | |
| EPS YoY % growth | N/A | N/A | -4.78 | -2.64 46.85% | -2.29 9.82% | -2.40 -4.78% | -2.74 -13.97% | -2.98 -9.07% | -2.10 29.74% | 2.18 204.14% | 4.91 124.77% | 6.11 24.53% | 9.70 58.76% |
All data in USD
| Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.54 3.32% | -0.52 6.76% | -0.59 8.50% | -0.60 -16.17% | -0.68 -25.31% | -0.70 -34.79% | -0.73 -23.48% | -0.81 -33.40% | -0.90 -32.30% |
| Revenue Q2Q % growth | N/A | N/A | N/A | N/A | |||||
| EBITDA Q2Q % growth | -22.542M -36.66% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -18.335M -7.87% | -18.835M -20.15% | -22.186M -18.75% | -23.454M -56.87% | -27.2M -48.35% | N/A | N/A | N/A | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2025 Q2Q % growth | -0.52 16.13% | -0.68 | 0.16 | 23.65% |
| Q2 2025 Q2Q % growth | -0.65 -8.33% | -0.63 | -0.02 | -3.96% |
| Q1 2025 Q2Q % growth | -0.56 26.32% | -0.62 | 0.06 | 9.70% |
| Q4 2024 Q2Q % growth | -0.56 92.79% | -0.66 | 0.10 | 15.54% |
| Q3 2024 Q2Q % growth | -0.62 | -0.67 | 0.05 | 6.96% |
| Q2 2024 Q2Q % growth | -0.60 | -0.68 | 0.08 | 12.20% |
| Q1 2024 Q2Q % growth | -0.76 | -0.47 | -0.29 | -61.28% |
| Q4 2023 Q2Q % growth | -7.77 | -1.70 | -6.07 | -356.11% |
| Period | Reported | Estimate | Difference | Surprise |
|---|
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 1.46% | 21.35% | 0% | 11.52% |
| Revenue | N/A | N/A | N/A | N/A |